Riedel's thyroiditis medical therapy: Difference between revisions

	Riedel's thyroiditis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Riedel's thyroiditis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Riedel's thyroiditis medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Riedel's thyroiditis medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Riedel's thyroiditis medical therapy
CDC on Riedel's thyroiditis medical therapy
Riedel's thyroiditis medical therapy in the news
Blogs on Riedel's thyroiditis medical therapy
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Riedel's thyroiditis medical therapy

VisualWikitext

Revision as of 13:29, 21 August 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

The mainstay of treatment for Riedel's thyroiditis is corticosteroid therapy. Tamoxifen has also been proposed as a part of the treatment plan.^[1]

Medical Therapy

Pharmacologic medical therapies for Riedel's thyroiditis include Corticosteroids and tamoxifen.

Treatment regimen for Riedel's thyroiditis

As is a Riedel's thyroiditis rare disease the effectiveness of therapy and dosages have not yet been assessed. As a result, dosage regimens and duration of therapy cannot be defined. The current recommendations are based on the clinical manifestations, associated conditions, and the response to treatment.

Adult
- Preferred regimen (1): Prednisone 15-60mg PO q24h for 6 months to 2 years
- Preferred regimen (2): Prednisone 500 mg PO q24h for 6 months to 2 years
- Alternative regimen (1): Tamoxifen 10-20 mg PO q24h for 6 months to 2 years
- Alternative regimen (1): Mycophenolate mofetil 1 g PO q12h for 6 months to 2 years
Pediatric
- Preferred regimen (1): Prednisone 15-60mg PO q24h for 6 months to 2 years
- Preferred regimen (2): Prednisone 500 mg PO q24h for 6 months to 2 years

References

↑ Dabelic N, Jukic T, Labar Z, Novosel SA, Matesa N, Kusic Z (2003). "Riedel's thyroiditis treated with tamoxifen" (PDF). Croat. Med. J. 44 (2): 239–41. PMID 12698518. Unknown parameter |month= ignored (help)

Template:WH Template:WS

[pmid12698518-1] Dabelic N, Jukic T, Labar Z, Novosel SA, Matesa N, Kusic Z (2003). "Riedel's thyroiditis treated with tamoxifen" (PDF). Croat. Med. J. 44 (2): 239–41. PMID 12698518. Unknown parameter |month= ignored (help)

[1]

@@ Line 9: / Line 9: @@
 *Pharmacologic medical therapies for Riedel's thyroiditis include Corticosteroids and tamoxifen.
-===Disease Name===
+===Treatment regimen for Riedel's thyroiditis===
+As is a Riedel's thyroiditis rare disease the effectiveness of therapy and dosages have not yet been assessed. As a result, dosage regimens and duration of therapy cannot be
+defined. The current recommendations are based on the clinical manifestations, associated conditions, and the response to treatment.
 *'''Adult'''
-** Preferred regimen (1): [[drug name]] 100 mg PO q12h for 10-21 days '''(Contraindications/specific instructions)'''
+** Preferred regimen (1): [[Prednisone]] 15-60mg PO q24h for 6 months to 2 years
-** Preferred regimen (2): [[drug name]] 500 mg PO q8h for 14-21 days
+** Preferred regimen (2): [[Prednisone]] 500 mg PO q24h for 6 months to 2 years
-***** Alternative regimen (1): [[drug name]] 500 mg PO q6h for 7–10 days
+** Alternative regimen (1): [[Tamoxifen]] 10-20 mg PO q24h for 6 months to 2 years
+** Alternative regimen (1): [[Mycophenolate mofetil]] 1 g PO q12h for 6 months to 2 years
 *'''Pediatric'''
-** Preferred regimen (1): [[drug name]] 50 mg/kg PO per day q8h (maximum, 500 mg per dose)
+** Preferred regimen (1): [[Prednisone]] 15-60mg PO q24h for 6 months to 2 years
-** Preferred regimen (2): [[drug name]] 30 mg/kg PO per day in 2 divided doses (maximum, 500 mg per dose)
+** Preferred regimen (2): [[Prednisone]] 500 mg PO q24h for 6 months to 2 years